Antigenic markers of T. gondii for chronic forms of toxoplasmosis in fertility age women
DOI:
https://doi.org/10.22317/imj.v8i1.1267Keywords:
toxoplasmosis, IgG avidity test, recomLine assay toxoplasma, abortion and toxoplasmosis.Abstract
Objective: This study aimed to assess the avidity of IgG antibodies against Toxoplasma gondii in fertile-aged women with a history of abortion. Using the recomLine Toxoplasma IgG Avidity kit, the research investigated the relationship between antibody avidity, T. gondii antigens (GRA1 and SAG1), and the number of abortions to enhance understanding of infection dynamics in this population.
Methods : Forty (40)fertile aged women (18-37years) with history of abortion and had positive results of IgG Abs by minividus form October 2021 to April 2022 ,Kit of recomLine Toxoplasma IgG Avidity form Mikrogen /Germany,item No.11010, was used ,which is a qualitative in vitro test for the determination the avidity of IgG antibodies against Toxoplasma gondii in human serum or plasma.
Results: Phase II of toxoplasmosis was positive of antibodies against different antigens detected by recomLine assay, no other significant relation was observed. Also, that there was no significant relation between the period of infection and avidity of IgG –Abs against different antigens of T.gondii detected by recomLine test. In addition The results showed that there was a significant relation between of the number of abortions to GRA1-antigen (P=0.012) and SAG1-antigen (P=0.003) .
Conclusion: There was a significant relation between of the number of abortions to GRA1 and SAG1-antigens detected by recomLine assay ,where increase in the positive results with the increase in the number of abortions.
References
Holec-Gasior L. 2013. Toxoplasma gondii Recombinant Antigens as Tools for Serodiagnosis of Human Toxoplasmosis: Current Status of Studies. Clin Vaccine Immunol. 20(9): 1343–1351.
Montoya JG. 2002. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J. Infect. Dis. 185:S73–S82.
Suzuki LA, Rocha RJ, Rossi CL. 2001. Evaluation of serological markers for the immunodiagnosis of acute acquired toxoplasmosis. J. Med. Microbiol. 50:62–70.
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. 1999.
Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829–1833.
Burg JL et al. 1988. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol. 141p. 3584–3581.
Findal G, Stray-Pedersen B, Holter EK, Berge T, Jenum PA. 2015. Persistent Low Toxoplasma IgG Avidity Is Common in Pregnancy: Experience from Antenatal Testing in Norway, PLoS One. 10(12): e0145519.
Remington JS MR, Wilson CB, Desmonts G. 2011. Toxoplasmosis. In: Remington JS KJ, editor. Infectious diseases of the fetus and newborn infant. 7th ed Philadelphia, PA: Saunders/Elsevier. p. 918–1041.
Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A, et al. 1998. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol. 36(10):2900–6.
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 353(9167):1829–33.
Montoya JG, Liesenfeld O. 2004. Toxoplasmosis. Lancet. 363(9425):1965–76.
Sensini A, Pascoli S, Marchetti D, Castronari R, Marangi M, Sbaraglia G, et al. 1996. IgG avidity in the serodiagnosis of acute Toxoplasma gondii infection: a multicenter study. Clin Microbiol Infect. 2(1):25–9.
Wong SY, Remington JS. 1994. Toxoplasmosis in pregnancy. Clin Infect Dis. 18(6):853–61; quiz 62.
Aref Teimouri, Sina Mohtasebi, Elham Kazemirad, Hossein Keshavarz. 2020. Role of Toxoplasma gondii IgG Avidity Testing in Discriminating between Acute and Chronic Toxoplasmosis in Pregnancy, J Clin Microbiol. 24;58(9):e00505–20.
Hedman K, Lappalainen M, Seppaia I, Makela O. 1989. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis. 159(4):736–40.
Jenum PA, Stray-Pedersen B, Gundersen AG. 1997. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol. 35(8):1972–7.
Murat JB, L’Ollivier C, Fricker Hidalgo H, Franck J, Pelloux H, Piarroux R. 2012. Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results. ClinVaccine Immunol. 19(11):1838–43.
Lindsay DS, Dubey JP. 2011. Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis. Parasitology 138:1829–1831.
Zedong Wang, Wei Ge, Si-Yang Huang, Jiping Li, Xing-Quan Zhu & Quan Liu. 2014. Evaluation of recombinant granule antigens GRA1 and GRA7 for serodiagnosis of Toxoplasma gondii infection in dogs, BMC Veterinary Research volume 10, Article number: 158.
Beghetto E.et al. 2003. Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J. Clin. Microbiol. 41 p.5414–5418.
Fatemeh Rezaei, Mahdi Sharif, Shahabeddin Sarvi, Seyed Hossein Hejazi, Sargis Aghayan, Abdol Sattar Pagheh, Samira Dodangeh, Ahmad Daryani. 2019. A systematic review on the role of GRA proteins of Toxoplasma gondii in host immunization, Journal of Microbiological Methods, Volume 165, 105696.
Zhou P, Chen Z, Li HL, Zheng H, He S, Lin RQ, Zhu XQ. 2011: Toxoplasma gondii infection in humans in China. Parasit Vectors. 4: 165.
Groβ U et al. 1992. Improved Serological Diagnosis of Toxoplasma gondii Infection by Detection of Immunoglobulin A(IgA) and IgM Antibodies against P30 Using the Immunoblot Technique. J. Clin. Microbiol. p.1436–1441.
Ho-Woo Nam: GRA Proteins of Toxoplasma gondii. 2009. Maintenance of Host-Parasite Interactions across the Parasitophorous Vacuolar Membran; Korean J Parasitol. 47(Suppl): S29–S37.
Harning D. et al. 1996. Recombinant Toxoplasma gondii surface antigen 1(P30) expressed in Escherichia coli is recognized by human Toxoplasma specific immunoglobulin M (IgM) and IgG antibodies. Clin. Diagn. Lab. Immunol., 3: p.355–357).
Carvalho FR.et al. 2008. Reverse Enzyme–Linked Immunosorbent Assay Using Monoclonal Antibodies against SAG1-Related Sequence, SAG2 and P97 Antigens from Toxoplasma Gondii To Detect Specific Imuunoglobulin G(IgG), IgM and IgA Antibodies in Human Sera, Clin. Vac. Immunol.p.1265–1271).
Holec–Gasior L. 2013. Toxoplasma gondii Recombinant Antigens as Tool for Serodiagnosis of Human Toxoplasmosis: Current Status of Stadies, Clin. And Vac. Immunol., 20p.1343–135.
Holec–Gasior L, Ferra B, Drapala D. 2012. MIC1-MAG1-SAG1 chimeric protein. A most effective antigen for detection of human toxoplasmosis. Clin. Vaccine Immunol. 19:1977–1979.